Dr. Alan Copperman: The Impact of Genomics on Infertility
Infertility has been a source of fascination to human beings
throughout our existence; a fact evident in some of the oldest and most
enduring of human legends. In one recent
online piece, Reproductive Endocrinologist and top fertility doctor Dr.
Alan Copperman briefly explores not only the history and evolution of this
long-held fascination, but of the ongoing “genomic revolution,” and how our
relatively newfound ability to analyze embryos at the genetic level is
transforming and will continue to shape our views of infertility for years to
come.
A Clinical
Professor of Obstetrics, Gynecology and Reproductive Science at Mount Sinai
Medical Center, as well as Chief Medical Officer at Sema4, a a health information company dedicated to improving the
diagnosis, treatment, and prevention of disease through deep data analysis,
Dr. Copperman examines how the science of genomics has opened the doors wide
open in terms of identifying and analyzing millions of data points on each
embryo, as well as identifying the healthiest embryo available for the patient.
Dr. Copperman posits the next step in the genomic revolution to be the
sequencing of whole genomes and transcriptomes; something that may make the
process of “fixing” disease genes within viable embryos routine procedure not
far down the road.
Though Dr. Alan Copperman
is optimistic about the potential of genomics to enhance fertility methods in
the future, he is careful to caution about the ethical protocols that will need
to be in place as the technology continues to move forward.
Comments
Post a Comment